Last reviewed · How we verify

conventional medicine + TCM — Competitive Intelligence Brief

conventional medicine + TCM (conventional medicine + TCM) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immune modulator. Area: Immunology.

phase 3 Immune modulator Immunology Small molecule Live · refreshed every 30 min

Target snapshot

conventional medicine + TCM (conventional medicine + TCM) — Henan University of Traditional Chinese Medicine. This conventional medicine combined with TCM works by modulating the body's immune response and reducing inflammation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
conventional medicine + TCM TARGET conventional medicine + TCM Henan University of Traditional Chinese Medicine phase 3 Immune modulator
Viral CTLs Viral CTLs New York Medical College phase 3 Immune modulator CD8+ T cells

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immune modulator class)

  1. Astellas Pharma China, Inc. · 1 drug in this class
  2. Henan University of Traditional Chinese Medicine · 1 drug in this class
  3. New York Medical College · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). conventional medicine + TCM — Competitive Intelligence Brief. https://druglandscape.com/ci/conventional-medicine-tcm. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: